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Generation of induced pluripotent stem (iPS) cells from bone-forming cells
Yin Xiang Wang
Department of Biochemistry, The University of Hong Kong
Osteochondroprogenitors uniquely co-expressing Sox9 and Runx2 with dual
differentiation potential to become chondrocytes and osteoblasts is an ideal
candidate for cell-based therapy. Therefore, developing approaches to generate
sufficient amounts of osteochondroprogenitors for skeletal regenerative medicine
are essential. Towards this, we take advantage of a reprogramming approach -
induced pluripotent stem (iPS) cells generation using osteoblasts. The selection of
osteoblasts is based on the hypothesis that it is originally derived from
osteochondroprogenitor lineage and the stochastic events of iPS induction might
revert osteoblasts first to their progenitor state before becoming pluripotent.
Sox9/Runx2 reporter mice will be generated using their regulatory sequences to
drive separate drug selection markers (neomycin and blasticidin) and two
fluorescence proteins (eYFP and mCherry) for identification and selection of
osteochondroprogenitors during reprogramming.
Our data showed that osteoblasts can be reprogrammed to iPS cells with
pluripotency potential as shown by their ability to form teratomas and contribute to
chimeric embryos. The system will enable us to test the possibility of “capturing”
or enriching for osteochondroprogenitors during the reprogramming process.
